Viewing by:
Surgeons successfully transported pig kidneys between Baltimore and Innsbruck five times using X-Therma’s FDA Breakthrough-designated subzero preservation technology
Learn how XT-ViVo® & TimeSeal® will enable multi-day preservation and remove time from the equation. The global shortage of transplantable organs is considered one of
In the past few years, specifically through the COVID-19 pandemic, supply-chain vulnerabilities have become the topic of everyday conversation across all industries— not just among
The cryopreservation of hematopoietic cells using dimethyl sulfoxide (DMSO) and serum is a common procedure used in transplantation. However, DMSO has clinical and biological side effects due to its toxicity, and serum introduces variation and safety risks. Explore the development of a novel class of ice-interactive cryoprotectants inspired by natural antifreeze proteins.
Existing and emerging biotech advances are transforming the way we preserve and transport donated organs. While their methods may vary, all share a common end
“Is it possible to achieve successful VCA transplantation after 72hrs ischemia at sub-zero temperature?” @X-Therma is pleased to get the answer revealed during the highly
We are honored to be featured in the May Issue of AIChE – American Institute of Chemical Engineers. Special thank you to the National Science
X-Therma was supported early on by the National Science Foundation (NSF) to develop ice-interactive biomimetic nanomaterial to advance biopreservation for unmet needs in Regenerative Medicine. We have
X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract. X-Therma’s CryomatrixTM is a new pipeline of non-toxic
X-Therma, Inc.
625 Alfred Nobel Drive
Suite B
Hercules, CA 94547
USA
X-Therma GmbH
Langer Weg 11
6020 Innsbruck
Austria
625 Alfred Nobel Drive
Suite B
Hercules, CA 94547
USA
X-Therma GmbH
Langer Weg 11
6020 Innsbruck
Austria
